000126939 001__ 126939
000126939 005__ 20240228140855.0
000126939 0247_ $$2doi$$a10.1249/MSS.0000000000000498
000126939 0247_ $$2pmid$$apmid:25202849
000126939 0247_ $$2ISSN$$a0025-7990
000126939 0247_ $$2ISSN$$a0195-9131
000126939 0247_ $$2ISSN$$a1530-0315
000126939 0247_ $$2altmetric$$aaltmetric:3919282
000126939 037__ $$aDKFZ-2017-02967
000126939 041__ $$aeng
000126939 082__ $$a610
000126939 1001_ $$0P:(DE-HGF)0$$aKuehl, Rea$$b0$$eFirst author
000126939 245__ $$aExercise intensity classification in cancer patients undergoing allogeneic HCT.
000126939 260__ $$aPhiladelphia, Pa.$$bLippincott Williams & Wilkins$$c2015
000126939 3367_ $$2DRIVER$$aarticle
000126939 3367_ $$2DataCite$$aOutput Types/Journal article
000126939 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1524037421_6842
000126939 3367_ $$2BibTeX$$aARTICLE
000126939 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000126939 3367_ $$00$$2EndNote$$aJournal Article
000126939 520__ $$aExercise intervention studies during and after cancer treatment show beneficial effects for various physical and psychosocial outcomes. Current exercise intensity guidelines for cancer patients are rather general and have been adapted from American College of Sports Medicine (ACSM) recommendations for healthy individuals. Intensive cancer treatment regimens such as allogeneic hematopoietic stem cell transplantation (allo-HCT) may change the cardiovascular response to acute exercise. Therefore, we evaluated the relationships between %V˙O2 reserve (%V˙O2R, reference) and %HRR, %HRmax, and %V˙O2max and compared calculated intensities with given intensities by ACSM.Measurements before and 180 d after allo-HCT from a randomized controlled trial were used. Only patients who reached maximal effort and at least two exercise stages in our maximal incremental cycling test were included. Before allo-HCT, 106 patients were included, and 180 d after treatment, 49 patients met our inclusion criteria. Individual regression lines were calculated with V˙O2R as the reference. Calculated exercise intensities for endurance training prescription were compared with ACSM values.Before allo-HCT, %HRR values of patients were significantly lower than ACSM values, and %HRmax and %V˙O2max values were significantly higher (except 90% HRmax, which was significantly lower, all P < 0.01). One hundred eighty days after allo-HCT, values for %HRR were not significantly different to ACSM values (except 90%, which was significantly lower, P = 0.01), whereas %HRmax and %V˙O2max were significantly higher (all P < 0.05). Furthermore, regression models revealed no influence of beta-blockers on calculated intensities.ACSM's exercise intensity recommendations for endurance training may not be applicable for cancer patients during and 180 d after allo-HCT because they may not meet the targeted intensity class, with the exception of %HRR 180 d after allo-HCT.
000126939 536__ $$0G:(DE-HGF)POF3-317$$a317 - Translational cancer research (POF3-317)$$cPOF3-317$$fPOF III$$x0
000126939 588__ $$aDataset connected to CrossRef, PubMed,
000126939 7001_ $$0P:(DE-He78)9fcfe1306c0e35afdc4503b65f496834$$aScharhag-Rosenberger, Friederike$$b1$$udkfz
000126939 7001_ $$aSchommer, Kai$$b2
000126939 7001_ $$0P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac$$aSchmidt, Martina$$b3$$udkfz
000126939 7001_ $$aDreger, Peter$$b4
000126939 7001_ $$aHuber, Gerhard$$b5
000126939 7001_ $$aBohus, Martin$$b6
000126939 7001_ $$aUlrich, Cornelia M$$b7
000126939 7001_ $$0P:(DE-He78)60b584aeef81e4c57fd111fa63779b73$$aWiskemann, Joachim$$b8$$eLast author$$udkfz
000126939 773__ $$0PERI:(DE-600)2031167-9$$a10.1249/MSS.0000000000000498$$gVol. 47, no. 5, p. 889 - 895$$n5$$p889 - 895$$tMedicine and science in sports and exercise$$v47$$x0195-9131$$y2015
000126939 909CO $$ooai:inrepo02.dkfz.de:126939$$pVDB
000126939 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000126939 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)9fcfe1306c0e35afdc4503b65f496834$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000126939 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000126939 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)60b584aeef81e4c57fd111fa63779b73$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000126939 9131_ $$0G:(DE-HGF)POF3-317$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vTranslational cancer research$$x0
000126939 9141_ $$y2015
000126939 915__ $$0StatID:(DE-HGF)0410$$2StatID$$aAllianz-Lizenz
000126939 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000126939 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000126939 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000126939 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000126939 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMED SCI SPORT EXER : 2015
000126939 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000126939 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000126939 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000126939 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000126939 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000126939 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000126939 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000126939 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000126939 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000126939 9201_ $$0I:(DE-He78)G110-20160331$$kG110$$lPräventive Onkologie$$x0
000126939 9201_ $$0I:(DE-He78)D120-20160331$$kD120$$lAngewandte Tumor-Immunität$$x1
000126939 9201_ $$0I:(DE-He78)G111-20160331$$kG111$$lBewegung, Sport und Krebs$$x2
000126939 980__ $$ajournal
000126939 980__ $$aVDB
000126939 980__ $$aI:(DE-He78)G110-20160331
000126939 980__ $$aI:(DE-He78)D120-20160331
000126939 980__ $$aI:(DE-He78)G111-20160331
000126939 980__ $$aUNRESTRICTED